![Eric Chesnel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Chesnel
Contatto Relazioni con gli Investitori presso Laboratoire Unither SASU
Profilo
Eric Chesnel is currently the Head of Media Relations at Laboratoire Unither SASU.
He previously worked as the Co-Chief Executive Officer at Unifin SAS.
Posizioni attive di Eric Chesnel
Società | Posizione | Inizio |
---|---|---|
Laboratoire Unither SASU
![]() Laboratoire Unither SASU Pharmaceuticals: MajorHealth Technology Laboratoire Unither SASU manufactures pharmaceutical products. It specializes in the development and contract manufacture of the pharmaceutical formulations like sterile unit dose vials with blow, fill and seal technology, effervescent tablets and liquid stick-packs. The company was founded in 1993 and is headquartered in Amiens, France. | Contatto Relazioni con gli Investitori | - |
Precedenti posizioni note di Eric Chesnel
Società | Posizione | Fine |
---|---|---|
Unifin SAS
![]() Unifin SAS Medical SpecialtiesHealth Technology Unifin SAS operates as an investment holding company which engages in pharmaceutical products and services. The company was founded on December 20, 2016 and is headquartered in Paris, France. | Amministratore Delegato | 07/01/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Laboratoire Unither SASU
![]() Laboratoire Unither SASU Pharmaceuticals: MajorHealth Technology Laboratoire Unither SASU manufactures pharmaceutical products. It specializes in the development and contract manufacture of the pharmaceutical formulations like sterile unit dose vials with blow, fill and seal technology, effervescent tablets and liquid stick-packs. The company was founded in 1993 and is headquartered in Amiens, France. | Health Technology |
Unifin SAS
![]() Unifin SAS Medical SpecialtiesHealth Technology Unifin SAS operates as an investment holding company which engages in pharmaceutical products and services. The company was founded on December 20, 2016 and is headquartered in Paris, France. | Health Technology |
- Borsa valori
- Insiders
- Eric Chesnel